Early Lyme borreliosis sera with significant titers of anti -outer surface protein C (OspC) borreliacidal antibodies were identified. Human anti-OspC borreliacidal antibodies could be either IgM or IgG. Significant concentrations of borreliacidal activity were detected after vaccination of mice with OspC. Detection of anti-OspC borreliacidal activity was dependent on surface expression of OspC by Borrelia burgdorferi isolate 50772. The ability of OspC to induce borreliacidal antibodies in vivo and after vaccination offers another possible explanation for the ability of vaccination with OspC to protect against infection with B. burgdorferi. Furthermore, detection of anti-OspC borreliacidal antibodies, especially IgM antibodies, in early Lyme borreliosis sera provides additional evidence that borreliacidal antibody detection may be useful for the serodiagnosis of early Lyme borreliosis.
Lyme borreliosis is a tick-associated zoonosis caused by that anti-OspA borreliacidal antibodies are responsible for providing protection after vaccination. Interestingly, OspC has also Borrelia burgdorferi sensu lato. This multisystem disorder has become the most common tick-transmitted disease in the been shown to provide protection. However, anti-OspC borreliacidal antibodies have not been detected after vaccination [14 -United States [1] and causes significant morbidity worldwide. Initially, spirochetes infect the skin and, in the majority of early 16] . In this investigation, we investigated whether OspC induces borreliacidal antibodies in vivo, because the ability of cases, cause an erythema migrans lesion [2] . If left untreated, spirochetes can disseminate to various tissues of the body, OspC vaccination to provide protection may also be dependent on borreliacidal antibodies. Borreliacidal antibodies have also including the heart, nervous system, or joints, and cause manifestations such as meningitis, facial palsy, atrioventricular heart been shown to serve as the basis for a sensitive and highly specific serodiagnostic test [17, 25 -27] . The ability to detect blockage, encephalopathy, polyneuropathy, and chronic arthritis [3 -6] .
anti-OspC borreliacidal antibodies would be useful for improving the serodiagnosis of Lyme borreliosis. Shortly after the discovery of Lyme borreliosis, researchers determined that vaccination of experimental animals with whole B. burgdorferi provided protection against challenge [7, Materials and Methods 8] . Additional studies established the role of antibody-mediated protection and confirmed the ability of vaccination with B.
Organisms. B. burgdorferi sensu stricto isolate 297 was isoburgdorferi to induce borreliacidal antibodies that specifically lated from human spinal fluid. B. burgdorferi sensu stricto isolate 50772, originally isolated from an Ixodes scapularis tick, was killed B. burgdorferi [9 -11] . To date, vaccination of animals especially OspA [12 -14] , OspB [12, 14] , and OspC [14 -16] , and hence does not express OspA or OspB [28] . The original have provided protection against infection with the Lyme spirosuspensions of spirochetes were serially 10-fold diluted in Bar- chete. Furthermore, OspA and OspB have been shown to inbour-Stoenner-Kelly (BSK) medium capable of supporting growth duce borreliacidal antibodies [13, 14, 17 -24] . from a single organism [29] . The resultant population of spiroOspA has received the most intense evaluation as a protecchetes was then passaged 10 times in fresh BSK medium at 30ЊC Branson Sonic Power, Danbury, CT). Sonicated E. coli were cengel without comb). Protein concentrations were determined with trifuged at 10,000 g for 15 min, and the supernatant was passed a protein determination kit (Bio-Rad, Richmond, CA). Two gels over a column containing SoftLink resin (Promega) at a rate of were run simultaneously in an electrophoresis unit (SE600; Hoefer 0.5 mL/min at 4ЊC. The column was then washed with 5 column Scientific, San Francisco) at 55 mA for 3 h with the buffer system vol of purification buffer. OspC was eluted with 5 mM biotin of Laemmli [31] . After electrophoresis, proteins were transferred (Sigma), and the recovered fractions were analyzed by SDSto nitrocellulose for 3 h at 300 mA under conditions described by PAGE. Towbin et al. [32] . The nitrocellulose was cut into strips and OspC ELISA. Recombinant OspC was diluted to 750 ng/mL blocked with PBS-0.3% Tween 20 for 30 min at 22ЊC. Strips in coating buffer (0.015 M Na 2 CO 3 , 0.035 M NaHCO 3 , pH 9.6), were incubated for 1 h at 22ЊC with human serum diluted 1:100 and 100-mL amounts were added to individual flat-bottom microtiand washed three times with PBS-0.05% Tween 20. Horseradish ter wells (Dynatech Laboratories, Chantilly, VA). Microtiter plates peroxidase-labeled anti-human IgM or IgG (heavy and light were incubated at 35ЊC for 4 h, followed by an overnight incubachains; Organon Teknika Cappel, Malvern, PA) was added, and tion at 4ЊC. After incubation, plates were washed three times with the strips were incubated for 30 min at 22ЊC. After incubation, PBS, pH 7.2, containing 0.05% Tween 20, sealed, and stored at strips were washed and developed (TMB Membrane Peroxidase 4ЊC. Before using, plates were blocked with PBS-0.05% Tween Substrate System; Kirkegaard & Perry Laboratories, Gaithersburg, 20 containing 1% bovine serum albumin for 30 min at 22ЊC and MD).
washed twice with PBS-0.05% Tween, and then 100 mL of serial Cloning and amplification of the ospC gene. Plasmid-enriched 2-fold dilutions of normal or Lyme borreliosis serum in PBS-0.05% DNA was isolated from B. burgdorferi sensu stricto isolate S-1-Tween were added to individual wells. Plates were incubated for 1 10 [13]. The DNA was used as a template for the amplification h at 22ЊC followed by three washes with PBS-0.05% Tween. Antiof the ospC gene (GeneAmp; Perkin Elmer Cetus, Norwalk, CT)
human IgM-horseradish peroxidase conjugate (100 mL; Organon [33] . Primers were used at a final concentration of 1.0 mM in a Teknika Cappel) diluted 1:3000 in PBS-0.05% Tween was added, 1.5-mM concentration of MgCl 2 . Thermal cycling parameters were and plates were incubated at 22ЊC for 1 h. After incubation, 100 mL 95ЊC for 5 min, followed by 35 cycles of 95ЊC for 30 s, 50ЊC for of o-phenylenediamine phosphate (0.4 mg/mL; Sigma) was added to 30 s, and 72ЊC for 90 s. The final extension was done at 72ЊC for each well and incubated at 22ЊC for 30 min. Reactions were stopped 7 min to fully extend any truncated DNA strands. The aminoby addition of 100 mL of 1 N H 2 SO 4 , and absorbances at 490 nm terminal primer C1 (5-CGTGGATCCATGAAAAAGAATACA-(model EL307; Bio-Tek Instruments, Winooski, VT) were immedi-TTAAGTGCGATA-3) and the carboxy-terminal primer C2 (5-ately determined. An optical density ú0.200 above that of the nor-AATTCCCGGGTTAAGGTTTTTTTGGACTTTCTGC-3) were mal serum control was considered positive. used for amplification. Underscores indicate regions recognized Detection of borreliacidal antibodies. The flow cytometric by the primers. Amplified DNA was purified with GeneClean borreliacidal antibody test was done as previously described [26, (Bio101, La Jolla, CA). After digestion with SmaI and BamHI 27]. Briefly, a frozen 200-mL aliquot of B. burgdorferi isolate (Gibco BRL, Gaithersburg, MD), purified DNA fragments were 50772 or 297 was thawed and inoculated into 6 mL of fresh BSK ligated into the PinPoint pXa-3 vector (Promega, Madison, WI) medium, and cultures were incubated for 72 h at 35ЊC. After with T4 DNA ligase (Gibco BRL). The ligation mixture was used incubation, the concentration of spirochetes was determined by to transform competent E. coli JM109. Transformed E. coli were use of a Petroff-Hausser counting chamber and diluted in fresh plated onto 21 tryptone-yeast (TY) medium containing ampicillin BSK medium to a concentration of 10 6 organisms/mL. Serum (100 mg/mL; Sigma, St. Louis) and incubated for 24 h at 37ЊC.
samples were diluted 1:20 in fresh BSK medium and sterilized by Colonies expressing OspC were detected by Western blot analysis passage through a 0.2-mm microfuge filter (Costar, Cambridge, using a strepavidin-horseradish peroxidase conjugate (Gibco MA). A 100-mL aliquot was transferred to a 1.5-mL screw-cap BRL) and an early Lyme disease serum containing anti-OspC antimicrofuge tube (Sarstedt), and the diluted serum was heat-inactibodies.
vated at 56ЊC for 10 min. After heat inactivation, a 100-mL aliquot The DNA sequence of the ospC gene was determined by doubleof B. burgdorferi 50772 and 15 mL of sterile guinea pig serum stranded sequencing (TaqTrack; Promega). Analysis and BLAST (200 50% hemolytic complement units/mL; Sigma) were added to searches were done with the GCG software system (GCG, Madithe diluted sera. After gentle agitation, the assay suspensions were son, WI Because anti-OspC borreliacidal antibodies were not dealiquots of each suspension were combined with 400 mL of 0.22-tected using B. burgdorferi 297, we hypothesized that detecmm-filter-sterilized PBS. These suspensions were then analyzed tion was dependent on the surface expression of OspC. As by using a FACScan flow cytometer (Becton Dickinson Immunocontrols, we incubated B. burgdorferi isolates 50772 or 297 cytometry Systems). Neutralization of borreliacidal activity. Borreliacidal activity of serum samples after removal of IgM or IgG antibodies was determined as previously described [17] . Briefly, 125 mL of dialyzed goat anti-human IgM or IgG (heavy and light chain; Kallestad Diagnostics, Chaska, MN) was added to 25 mL of normal or Lyme borreliosis serum, and the mixture was incubated for 2 h at 37ЊC. After centrifugation at 5000 g for 10 min (Surespin; Helena Laboratories, Beaumont, TX), the supernatant was diluted 2-fold with fresh BSK medium, sterilized by passage through a 0.2-mm microfuge filter (Costar), and assayed for borreliacidal activity. dorferi 297 (lane B) grown at 35ЊC and Adsorption of Lyme borreliosis sera with rOspC. Adsorption mouse serum containing anti-OspC antiof anti-OspC antibodies from Lyme borreliosis sera was done by bodies. a modification of a previously described procedure [17] . TetraLink Tetrameric Avidin Resin (Promega) was washed with PBS, and a 1-mL volume was loaded into a column. Three micrograms of dialyzed biotinylated rOspC in a 1-mL volume was passed over the column, and absorbance at 280 nm was monitored to confirm binding of OspC to the column. A 1-mL sample of each of 10 human Lyme borreliosis sera diluted 10-fold with PBS (pH 7.2) was then passed over the column 10-15 times at 4ЊC to remove with serum obtained from rOspC-vaccinated mice before ( figure 2B ). Since the organisms were viable, these results indicated that little or no OspC was expressed on the surface treatment with FITC-conjugated goat anti-mouse IgG and then determined the fluorescence intensity of the live spiroof B. burgdorferi 297. In contrast, the MCF of B. burgdorferi 50772 was 2677 units when these spirochetes were incubated chetes by flow cytometry. When B. burgdorferi 297 or 50772 was incubated with FITC-conjugated goat anti-mouse IgG, with mouse anti-OspC serum (1:40) and FITC-labeled antimouse IgG ( figure 2D ). In addition, significantly increased the mean channel fluorescence intensity (MCF) of these spirochetes was 275 and 290 units, respectively (figure 2A, fluorescence intensity was detectable, even when mouse antiOspC serum was diluted 1:40,960 (figure 3). These results 2C). Similarly, when B. burgdorferi 297 organisms were incubated with a 1:40 dilution of mouse anti-OspC serum support our hypothesis that the surface of B. burgdorferi 50772 contains a significant concentration of OspC. and FITC-labeled anti-mouse IgG, the MCF was 346 units 
Effect of removal of anti-OspC antibodies on borreliacidal bodies by Western blotting (figure 4)
. In addition, the antiOspC ELISA reactivity decreased to levels similar to that of the activity. Early Lyme borreliosis sera were screened for antiOspC antibodies by an OspC ELISA, and 10 serum samples normal serum control. Concomitantly, there was a significant reduction in the titers of borreliacidal antibodies (table 1) . Borcontaining anti-OspC antibodies were selected. The borreliacidal activity of these sera was determined with B. burgdorferi reliacidal activity decreased in 8 (80%) of the serum samples to £40 (normal background). The borreliacidal antibody titers 50772 grown at 35ЊC. High titers of borreliacidal antibodies (range, 640 -40,960) were detected with the sera (table 1) .
decreased from 10,240 to 320 in the remaining 2 serum samples. Subsequently, each of the 10 early Lyme borreliosis sera was passed 10 -15 times over a column containing rOspC. The
To affirm that the borreliacidal antibodies were OspC-specific, the captured antibodies were eluted from the OspC colremoval of anti-OspC antibodies was considered complete because the eluted sera failed to demonstrate anti -22-kDa antiumn and tested for anti-OspC antibodies and borreliacidal ac- tivity. Anti-OspC antibodies were readily detected in the No borreliacidal activity was detected in either treated or untreated normal serum. These results affirm our previous obserfractions by Western blotting. Similarly, significant borreliacidal activity with titers as high as 640 was detected (data not vations [17] that human borreliacidal antibodies can be either IgM or IgG. shown). Collectively, these results demonstrate that high titers of anti-OspC borreliacidal antibodies were produced in sera Induction of anti-OspC borreliacidal antibodies. We next determined whether vaccination of mice with rOspC induced shortly after natural infection with the Lyme borreliosis spirochete.
anti-OspC borreliacidal antibodies. No borreliacidal activity was detected when B. burgdorferi isolate 297 was used. HowClasses of anti-OspC borreliacidal antibodies. Borreliacidal activity was decreased in 9 (90%) of the early Lyme borrelever, significant borreliacidal activity (titer §640) was detected with B. burgdorferi isolate 50772. These results show that iosis sera after treatment with anti-human IgM serum, but not after treatment with anti-human IgG antibodies (table 2) . When vaccination with OspC induces borreliacidal antibodies. These results also confirm our finding with naturally infected human the remaining serum was treated with anti-human IgG antibodies, the borreliacidal titer decreased 8-fold. Normal human sesera that detection of OspC borreliacidal antibody is dependent on surface expression of OspC by B. burgdorferi isolate 50772. rum was also treated with anti-human IgM or IgG antibodies. The use of borreliacidal assays to monitor the levels of anti-10 1280 1280 160
Discussion
OspA borreliacidal antibodies has provided important insight [19, 20] have confirmed the high specificity of the borrelIn this investigation, we demonstrate the ability of B. burgdorferi OspC to induce high levels of borreliacidal antibodies iacidal antibody test using B. burgdorferi isolate 297. For example, we did not detect borreliacidal activity in 104 serum shortly after infection. Detection was dependent on the presence of high levels of OspC on the surface of B. burgdorferi.
samples from patients with syphilis, mononucleosis, systemic lupus erythematosus, rheumatoid factor, or antinuclear antiWe also showed that vaccination of mice with OspC induced significant levels of anti-OspC borreliacidal antibodies. These body positivity [26] . In contrast, 47 (45%) of these sera yielded positive results when tested by ELISA. Highly specific IgM or antibodies, however, were detected only when B. burgdorferi isolate 50772, which expresses high levels of OspC on the IgG borreliacidal antibodies against B. burgdorferi isolate 297, which expresses OspA and OspB, were detected in early or surface, was used. In support, we showed that B. burgdorferi isolate 297, which expresses OspA, OspB, and OspC, failed late Lyme borreliosis sera [17, 26, 27] . However, high levels of borreliacidal antibodies against isolate 297 were detected to detect borreliacidal antibodies in sera from patients with early Lyme borreliosis and mice after vaccination with OspC primarily in sera from patients with late stages of the disease [17 -19] or in convalescent sera collected weeks to months because of the absence of OspC on the surface of the spirochetes. Additional studies are currently being done to determine after diagnosing patients with early Lyme borreliosis [20] . When early Lyme borreliosis sera were tested, we [27] and whether anti-OspC borreliacidal antibodies are responsible for vaccine-induced immunity. Identification of B. burgdorferi isoAgger and Case [45] detected anti -B. burgdorferi 297 borreliacidal antibodies in only 15% and 12.5% of patients, respeclate 50772 as an excellent monitor of anti-OspC borreliacidal activity will expedite these investigations.
tively. When B. burgdorferi isolate 50772 was used, we [27] detected highly specific borreliacidal antibodies in 34 (72%) The detection of anti-OspC borreliacidal antibodies shortly after infection with B. burgdorferi also provides insight into of 47 culture-or case-defined early Lyme borreliosis sera from patients from Westchester County. We also confirmed the high a progression of antigenic changes that may allow infecting spirochetes to evade the host protective immune response. B.
specificity of borreliacidal activity against B. burgdorferi 50772. No borreliacidal antibodies were detected in normal burgdorferi organisms appear to up-regulate OspC and concomitantly down-regulate OspA shortly before tick inoculation sera or sera from patients with syphilis, mononucleosis, or rheumatoid factor [27] . In this investigation, we extended these of the host with the spirochete [36, 37] . Consequently, antiOspC antibodies are among the first antibody responses defindings by demonstrating that IgM and IgG borreliacidal antibodies in early Lyme borreliosis sera can be OspC-specific. tected in patients with early Lyme borreliosis, while detection
